Dudley Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.15M | Sell |
22,377
-59
| -0.3% | -$11K | 2.07% | 11 |
|
2025
Q1 | $4.7M | Sell |
22,436
-619
| -3% | -$130K | 2.46% | 10 |
|
2024
Q4 | $4.1M | Buy |
23,055
+28
| +0.1% | +$4.98K | 2.06% | 11 |
|
2024
Q3 | $4.55M | Buy |
23,027
+5
| +0% | +$987 | 2.35% | 10 |
|
2024
Q2 | $3.95M | Buy |
23,022
+6
| +0% | +$1.03K | 2.19% | 10 |
|
2024
Q1 | $4.16M | Sell |
23,016
-194
| -0.8% | -$35.1K | 2.43% | 10 |
|
2023
Q4 | $3.6M | Buy |
23,210
+106
| +0.5% | +$16.4K | 2.29% | 9 |
|
2023
Q3 | $3.44M | Buy |
23,104
+248
| +1% | +$37K | 2.42% | 8 |
|
2023
Q2 | $3.08M | Sell |
22,856
-1,222
| -5% | -$165K | 2.07% | 11 |
|
2023
Q1 | $3.84M | Buy |
24,078
+313
| +1% | +$49.9K | 2.61% | 6 |
|
2022
Q4 | $3.84M | Buy |
+23,765
| New | +$3.84M | 2.69% | 6 |
|